HIV Curriculum

Prevention

Updated 3/2021

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER)

10/2020 HIV JC Article

Testing

Anti-Retroviral (ARV) Regimens

Updated 3/2021

AIDSInfo Initiating ART Guidelines

INSIGHT-START Trial: Early Initiation of ART

SMART Trial: Early Initiation of ART

Cochrane Review: Rapid ART Initiation

Current Opinion in HIV and AIDS: HIV treatment, 2019

The ART of Antiretroviral Therapy in Critically Ill Patients with HIV

RCT: Raltegravir-intensified initial ART therapy in adv HIV

Initiation of ART Containing INSTI Increases Risk of IRIS Requiring Hospitalization

INSTIs and the Emergence of IRIS

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

2/2021 HIC JC Article

ARV Contraindications, Interactions, and Adverse Effects

Mutations

Updated 3/2021

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations

11/2020 HIV JC Article

Vaccines for the HIV Patient

Updated 3/2021

Vaccination guidance for patients living with HIV

Systemic review and meta-analysis of immune response of double dose of HBV vaccine in HIV-infected patients

Perinatal Care for the HIV Patient

Healthcare Maintenance for the HIV Patient

Social Determinants in HIV Care

Novel ARVs

Updated 3/2021

Combination of long-acting HIV fusion inhibitor albuvirtide and LPV/r showed potent efficacy in HIV-1 patients

Emerging reverse transcriptase inhibitors for HIV-1 infection

Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD)

Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1

Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection

ARV Pipeline

Updates on HIV Vaccine Development

Updated 3/2021

HIV Vaccination: A Roadmap among Advancements and Concerns

Off the beaten path: Novel mRNA-nanoformulations for therapeutic vaccination against HIV